The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Re-visiting EGFR amplification as a target for anti-EGFR therapy: Analysis of cell-free circulating tumor DNA in patients with diverse cancers.
 
Shumei Kato
No Relationships to Disclose
 
Ryosuke Okamura
No Relationships to Disclose
 
Manvita Mareboina
No Relationships to Disclose
 
Suzanna Lee
No Relationships to Disclose
 
Aaron Goodman
Consulting or Advisory Role - Gerson Lehrman Group; Mitsubishi Tanabe Pharma
 
Sandip Pravin Patel
Consulting or Advisory Role - Lilly; Novartis
Speakers' Bureau - Boehringer Ingelheim; Merck
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Pfizer (Inst); Roche/Genentech (Inst); Xcovery (Inst)
 
Paul T. Fanta
No Relationships to Disclose
 
Richard B. Schwab
Stock and Other Ownership Interests - Samumed (I)
Consulting or Advisory Role - Human Longevity, Inc
Patents, Royalties, Other Intellectual Property - The patent covers sialylated glycans and antibodies that specifically bind to them for early detection and diagnosis of cancer. (Inst)
 
Jason K. Sicklick
Consulting or Advisory Role - bioTheranostics; Grand Rounds; Loxo
Research Funding - Blueprint Medicines; Foundation Medicine; Novartis
 
Victoria M. Raymond
Employment - Guardant Health; Trovagene
Stock and Other Ownership Interests - Guardant Health; Trovagene
 
Richard B. Lanman
Employment - Guardant Health; Veracyte
Leadership - Biolase; Guardant Health
Stock and Other Ownership Interests - Biolase; Guardant Health
Research Funding - Guardant Health
 
Razelle Kurzrock
Leadership - CureMatch
Stock and Other Ownership Interests - CureMatch
Consulting or Advisory Role - Actuate Therapeutics; Loxo; Sequenom
Speakers' Bureau - Roche
Research Funding - Foundation Medicine (Inst); Genentech (Inst); Guardant Health (Inst); Incyte (Inst); Merck Serono (Inst); Pfizer (Inst); Sequenom (Inst)